GMP Certificate of Compliance: Insulin Analogs, GLP-1s, Injectable Biologics & 506E Sterile Drugs
MayMag Biologics holds a current GMP Certificate of Compliance (No. INGM/AN-27354/130977/0626) issued by United Accreditation Management Licensing Services, covering Insulin Analogs & GLP-1s, Injectable Biologics, 503B & 506E Sterile Drugs, and Clinical & Investigational New Drugs.
MayMag Biologics (formerly Tirzepatide Pharm Corp, dba Zeptide Pharma) is proud to hold a current GMP Certificate of Compliance issued by United Accreditation Management Licensing Services (UAMLS), confirming that our management system meets the requirements of Good Manufacturing Practice (GMP) across a comprehensive scope of pharmaceutical manufacturing activities.
Certificate Details
| Field | Details |
|---|---|
| Certificate No. | INGM/AN-27354/130977/0626 |
| Issued to | Tirzepatide Pharm Corp (dba Zeptide Pharma / MayMag Biologics) |
| Address | 10200 Plano Road, Dallas TX 75238, USA |
| Registered on | June 30, 2026 |
| Issued on | June 30, 2026 |
| Expires on | June 29, 2029 |
| Issuing Body | United Accreditation Management Licensing Services (UAMLS) |
Certified Scope
This GMP Certificate of Compliance covers the following manufacturing categories:
- Insulin Analogs & GLP-1s — including tirzepatide, semaglutide analogs, and insulin glargine
- Injectable Biologics — sterile biologic drug products for parenteral administration
- 503B & 506E Sterile Drugs — large-scale outsourcing facility compounding under FDA DQSA designation
- Clinical & Investigational New Drugs (IND) — manufacturing support for clinical trial phases
What GMP Certification Means for Our Partners
GMP (Good Manufacturing Practice) certification confirms that a manufacturer's systems, processes, and facilities consistently produce pharmaceutical products that meet defined quality standards. For MayMag Biologics' partners and clients, this certification provides independent, third-party verification that:
- Our manufacturing processes are documented, validated, and reproducible
- Our facilities meet international standards for cleanliness, environmental control, and equipment qualification
- Our quality management systems include robust change control, deviation management, and CAPA processes
- Our products are manufactured under conditions that protect patient safety and product integrity
Verify This Certificate
This certificate can be independently verified at www.uamls.org.uk/certified-clients.php.
Our Full Regulatory Credential Stack
In addition to this GMP Certificate of Compliance, MayMag Biologics operates under:
- FDA registration as a 506(e) outsourcing facility (DQSA)
- cGMP compliance — 21 CFR Parts 210–211
- ISO 13485 certification
- USP Chapter 797 compliance (sterile compounding)
- USP Chapter 800 compliance (hazardous drug handling)
For partnership and RFQ inquiries, visit peptidences.com/contact.
Explore Topics
Written by
MayMag Biologics
Content creator and writer sharing insights and stories.
